Sign Up Today and Learn More About Tessa Therapeutics Stock
Invest in or calculate the value of your shares in Tessa Therapeutics or other pre-IPO companies through EquityZen's platform.
Tessa Therapeutics Stock (TEST)
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.
About Tessa Therapeutics Stock
Founded
2001
Industries
Science and Engineering, Health Care, Biotechnology
Tessa Therapeutics Press Mentions
Stay in the know about the latest news on Tessa Therapeutics
10 biotech companies to watch in 2023
labiotech • May 04, 2024
Cell Therapy Market Size to Grow At 22.67% CAGR Till 2033
biospace • May 04, 2024
Tessa Therapeutics dissolves after raising more than $200M
fiercebiotech • Jul 07, 2023
Singapore cancer cell therapy startup Tessa Therapeutics to shut down
endpts • Jul 07, 2023
Temasek-backed Tessa Therapeutics to cease operations after failure to raise funding
bt • Jun 30, 2023
Tessa Therapeutics Management
Leadership team at Tessa Therapeutics
Chief Financial Officer
Wilson Cheung
Board Member
Amy Schulman
Join now and verify your accreditation status to gain access to:
- Tessa Therapeutics current valuation
- Tessa Therapeutics stock price
- Available deals in Tessa Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Tessa Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Tessa Therapeutics through EquityZen funds. These investments are made available by existing Tessa Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tessa Therapeutics stock?
Shareholders can sell their Tessa Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."